Antibiotic Allergy Management

Introduction to Penicillin Allergy

• Penicillin allergy can be categorized into Type I (Immediate/Anaphylactic) Hypersensitivity and Non-Type I Hypersensitivity, with Type I characterized by anaphylaxis, angioedema, bronchospasm, or urticaria occurring within minutes to hours after exposure, and Non-Type I characterized by delayed rashes or other non-immediate reactions typically occurring >24 hours after exposure 1, 2, 3
• Approximately 90% of patients with reported penicillin allergy are not truly allergic when tested, and formal allergy evaluation should be considered when appropriate 1, 3, 4

Alternative Antibiotics for Penicillin Allergy

• For patients with non-severe, delayed-type penicillin allergy, cephalosporins with dissimilar side chains may be considered due to their low cross-reactivity of approximately 2% 5
• Cephalexin can be an option for patients with non-severe, delayed-type penicillin allergy if there was no immediate hypersensitivity reaction to penicillin, as recommended by the Infectious Diseases Society of America 6, 5
• The Centers for Disease Control and Prevention recommends doxycycline, tetracycline, clindamycin, macrolides, and certain cephalosporins as alternatives for patients with penicillin allergy, with the specific choice depending on the type of infection and severity of the allergic reaction 7
• Doxycycline 100 mg orally twice daily for 2 weeks is a first-choice alternative for patients with penicillin allergy 7
• Clindamycin 300-450 mg orally three times daily for 7-10 days is a first-choice alternative for patients with penicillin allergy 6
• Azithromycin is recommended at a dose of 500 mg on day 1, then 250 mg daily for 4 days (adults) or 12 mg/kg/day for 5 days (children) by the Infectious Diseases Society of America 1, 8
• Erythromycin is recommended as an effective alternative for patients allergic to both penicillin and sulfa drugs by the American Heart Association 9
• Moxifloxacin is suggested as a particularly effective option for respiratory infections by the American Academy of Otolaryngology-Head and Neck Surgery, but has a higher risk of adverse reactions compared to other fluoroquinolones 5, 10

Treatment Duration and Considerations

• The recommended treatment durations are:

  Antibiotic	Duration
  Clindamycin	10 days
  Cephalosporins	10 days
  Azithromycin	5 days
  Clarithromycin/Erythromycin	10 days
  Doxycycline	10 days
  Levofloxacin	5-10 days

• For severe infections, combination therapy with clindamycin plus another agent with gram-negative coverage may be necessary, as recommended by the Clinical Infectious Diseases guidelines 6
• For immunocompromised patients, more aggressive therapy may be warranted with close monitoring, and for pregnant patients, clindamycin is generally considered safe in pregnancy (Category B) 6
• Using broad-spectrum antibiotics unnecessarily (e.g., fluoroquinolones) is discouraged, as stated by the Circulation guidelines 9
• Inadequate treatment duration increases the risk of rheumatic fever, as warned by the Clinical Microbiology and Infection and Circulation guidelines 11, 9

Diagnosis and Treatment Assessment

• Confirming the diagnosis of Group A Streptococcal (GAS) pharyngitis using rapid antigen detection test (RADT) and/or throat culture before initiating treatment is recommended, as suggested by the American Academy of Family Physicians 12
• Response to therapy should be assessed within 48-72 hours, with consideration of alternative diagnosis or treatment if no improvement after 72 hours 1
• Patient factors, such as age, compliance history, previous treatment failures, and local resistance patterns, should be considered when selecting an appropriate agent, as recommended by the American Academy of Family Physicians 12, 13
• Avoid unnecessary testing/treatment of asymptomatic contacts and ensure proper diagnosis before initiating antibiotics to prevent overtreatment of viral pharyngitis, as cautioned by the American Academy of Family Physicians 12, 13